UPDATED Oct 03, 2022
Discover large cap Australian Pharmaceuticals & Biotech companies that are on the ASX. These Pharmaceuticals & Biotech Companies are organised by Market Cap.
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
| CSLCSL | AU$287.40 | 1.8% | 0.4% | AU$138.6b | AU$329.21 | PE40x | E13.8% | 1.2% | ||
| TLXTelix Pharmaceuticals | AU$4.98 | 9.2% | -8.8% | AU$1.6b | AU$9.24 | PS54.3x | E76.4% | n/a | ||
| IMUImugene | AU$0.19 | 5.6% | -53.7% | AU$1.2b | n/a | PS92.2x | E6.0% | n/a | ||
| CUVClinuvel Pharmaceuticals | AU$19.35 | 9.6% | -51.9% | AU$956.1m | AU$26.00 | PE45.8x | E30.3% | 0.2% | ||
| NEUNeuren Pharmaceuticals | AU$6.31 | -2.2% | 207.8% | AU$794.8m | AU$7.83 | PS248.7x | E53.4% | n/a | ||
| MSBMesoblast | AU$0.84 | 1.2% | -44.6% | AU$619.2m | AU$1.45 | PS39.5x | E61.0% | n/a | ||
| OPTOpthea | AU$1.13 | 0.9% | -13.7% | AU$525.2m | AU$1.70 | PS1752.8x | E38.7% | n/a | ||
| MYXMayne Pharma Group | AU$0.28 | 7.5% | -9.5% | AU$495.8m | n/a | PS1.2x | E113.4% | 0% | ||
| PARParadigm Biopharmaceuticals | AU$1.51 | 26.9% | -22.0% | AU$430.4m | AU$1.90 | PS5592.6x | E70.6% | n/a | ||
| IHLIncannex Healthcare | AU$0.26 | 4.0% | -21.2% | AU$398.3m | n/a | PS509.8x | E-40.3% | n/a | ||
| CAUCronos Australia | AU$0.68 | -0.7% | 297.1% | AU$374.2m | n/a | PE62.3x | S33.5% | 1.5% | ||
| TRJTrajan Group Holdings | AU$2.00 | 0% | -32.0% | AU$304.2m | AU$3.22 | PE178.6x | E43.3% | n/a | ||
| RACRace Oncology | AU$1.90 | -5.0% | -39.7% | AU$301.9m | n/a | PS396.7x | n/a | n/a | ||
| ARXAroa Biosurgery | AU$0.76 | 0% | -38.0% | AU$260.5m | AU$1.20 | PS7.5x | E68.3% | n/a | ||
| SPLStarpharma Holdings | AU$0.60 | 4.3% | -49.6% | AU$247.1m | AU$1.00 | PS47.9x | E0.9% | n/a | ||
| PYCPYC Therapeutics | AU$0.07 | 0% | -51.7% | AU$222.7m | n/a | PS13.9x | n/a | n/a | ||
| IMMImmutep | AU$0.26 | 2.0% | -50.5% | AU$222.6m | AU$1.16 | PS47.2x | E60.6% | n/a | ||
| AVHAVITA Medical | AU$1.63 | -3.3% | -65.7% | AU$204.0m | AU$3.46 | PS5.4x | E29.5% | n/a | ||
| PBPProbiotec | AU$2.22 | -0.9% | -0.9% | AU$180.5m | AU$3.24 | PE13.2x | E10.3% | 2.5% | ||
| CU6Clarity Pharmaceuticals | AU$0.63 | 0% | -44.5% | AU$162.8m | AU$1.70 | PS25.2x | E81.6% | n/a | ||
| ACWActinogen Medical | AU$0.089 | 18.7% | -15.2% | AU$159.8m | n/a | PS44.1x | E3.4% | n/a | ||
| MVPMedical Developments International | AU$1.64 | 4.8% | -68.5% | AU$141.5m | AU$3.12 | PS6.3x | E79.5% | 0% | ||
| RCERecce Pharmaceuticals | AU$0.78 | 6.2% | -16.7% | AU$138.0m | n/a | PS44.7x | n/a | n/a | ||
| GSSGenetic Signatures | AU$0.88 | 6.7% | -36.9% | AU$126.2m | AU$1.20 | PE41.2x | E-30.8% | n/a |